{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:32:23Z","timestamp":1793820743265,"version":"4.6.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic peripheral neuropathy (DPN) is a prevalent and highly disabling complication of diabetes mellitus, associated with markedly increased rates of disability and mortality. Timely intervention and effective management have been consistently shown to substantially reduce the risk of DPN onset and progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study analyzed 1, 004 hospitalized patients with type 2 diabetes mellitus (T2DM) admitted to the endocrinology department of a hospital in Jiangsu Province, China. A risk prediction model for DPN was developed using the Random Forest (RF) algorithm, while logistic regression analysis was employed to identify the major risk factors. The overarching aim was to provide a reliable risk assessment tool for clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Five principal factors were identified as significantly associated with DPN risk: age (OR = 1.257, 95% CI [1.188\u20131.367], p &amp;lt; 0.001), serum 25(OH)D3 levels (OR = 0.791, 95% CI [0.759\u20130.854], p &amp;lt; 0.001), duration of diabetes (OR = 1.431, 95% CI [1.285\u20131.617], p &amp;lt; 0.001), glycated hemoglobin (HbA1c) (OR = 1.236, 95% CI [1.197\u20131.391], p &amp;lt; 0.001), and glycated serum protein (GSP) (OR = 1.091, 95% CI [1.047\u20131.201], p = 0.017). A DPN risk prediction model incorporating these variables achieved an area under the receiver operating characteristic curve (AUC) of 0.829 (95% CI: 0.802\u20130.857), demonstrating excellent discriminatory performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>The Random Forest\u2013based DPN risk prediction model successfully identified five critical risk factors, offering a solid theoretical foundation for personalized strategies in DPN prevention and management among patients with diabetes. This model exhibits high predictive utility in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1740545","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:52:07Z","timestamp":1767768727000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Deep exploration and precise identification of key risk factors for diabetic peripheral neuropathy using the random forest algorithm"],"prefix":"10.3389","volume":"16","author":[{"given":"Yongnan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000210","article-title":"Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data","volume":"9","author":"Heald","year":"2020","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","volume-title":"IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS [Internet]","author":"Magliano","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00188-0","article-title":"Towards prevention of diabetic peripheral neuropathy: Clinical presentation, pathogenesis, and new treatments","volume":"21","author":"Elafros","year":"2022","journal-title":"Lancet Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.2337\/dc18-S010","article-title":"10. Microvascular complications and foot care: standards of medical care in diabetes-2018[J","volume":"41","author":"Association","year":"2018","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10395","DOI":"10.3390\/ijms251910395","article-title":"Update on biomarkers of chronic inflammatory processes underlying diabetic neuropathy","volume":"25","author":"Stoian","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12902-024-01728-9","article-title":"Establishment and external validation of an early warning model of diabetic peripheral neuropathy based on random forest and logistic regression","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"B8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/acn3.531","article-title":"Diabetes and obesity are the main metabolic drivers of peripheral neuropathy","volume":"5","author":"Callaghan","year":"2018","journal-title":"Ann Clin Trans Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.3745","article-title":"Association between metabolic syndrome components and polyneuropathy in an obese population","volume":"73","author":"Callaghan","year":"2016","journal-title":"JAMA Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12911-025-03201-6","article-title":"Machine learning in the prediction of diabetic peripheral neuropathy: a systematic review","volume":"25","author":"Ma","year":"2025","journal-title":"BMC Med Inform Decis Mak"},{"key":"B11","doi-asserted-by":"publisher","first-page":"20962","DOI":"10.1038\/s41598-025-07774-0","article-title":"Predicting diabetic peripheral neuropathy through advanced plantar pressure analysis: a machine learning approach","volume":"15","author":"Sheikh","year":"2025","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-024-01728-9","article-title":"Establishment and external validation of an early warning model of diabetic peripheral neuropathy based on random forest and logistic regression[J","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Endoc Disord"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1038\/s41598-020-62133-5","article-title":"Study of cardiovascular disease prediction model based on random forest in eastern China[J","volume":"10","author":"Yang","year":"2020","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3760\/cma.j.cn115791-20210221-00095","article-title":". Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)","volume":"13","year":"2021","journal-title":"Chin J Diabetes Mellitus"},{"key":"B15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-025-02175-1","article-title":"Diabetic neuropathy: cutting-edge research and future directions","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct Targ Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e30004","DOI":"10.7759\/cureus.30004","article-title":"Diabetic polyneuropathy in type 1 and type 2 diabetes mellitus: A cross-sectional study","volume":"14","author":"Hindi","year":"2022","journal-title":"Cureus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/diagnostics13071265","article-title":"Training and external validation of a predict nomogram for type 2 diabetic peripheral neuropathy","volume":"13","author":"Li","year":"2023","journal-title":"Diagnostics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.05.005","article-title":"Diabetic neuropathy: mechanisms to management","volume":"120","author":"Edwards","year":"2008","journal-title":"Pharmacol Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/CIN.0000000000001157","article-title":"Construction of an early risk prediction model for type 2 diabetic peripheral neuropathy based on random forest","volume":"42","author":"Wei","year":"2024","journal-title":"CIN: Comput Inform Nurs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e20208","DOI":"10.7759\/cureus.20208","article-title":"Effectiveness of empagliflozin with vitamin D supplementation in peripheral neuropathy in type 2 diabetic patients","volume":"13","author":"Mehta","year":"2021","journal-title":"Cureus"},{"key":"B21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000375304","article-title":"Prospective evaluation of the effect of short-term oral vitamin D supplementation on peripheral neuropathy in type 2 diabetes mellitus","volume":"24","author":"Shehab","year":"2015","journal-title":"Med Princ Pract"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1354511","article-title":"Association of vitamin D deficiency and subclinical diabetic peripheral neuropathy in type 2 diabetes patients","volume":"15","author":"Sun","year":"2024","journal-title":"Front Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.54029\/2023eww","article-title":"The association of vitamin D level with diabetic peripheral neuropathy: A comparative crosssectional study","volume":"28","author":"Rahaman","year":"2023","journal-title":"Neurol Asia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"102064","DOI":"10.1016\/j.arr.2023.102064","article-title":"How vitamins act as novel agents for ameliorating diabetic peripheral neuropathy: A comprehensive overview","volume":"91","author":"Li","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/TEN.0b013e3181594284","article-title":"Is vitamin D insufficiency associated with peripheral neuropathy","volume":"17","author":"Carlson","year":"2007","journal-title":"Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.1.4858","article-title":"1, 25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs1","volume":"138","author":"Ines","year":"1997","journal-title":"Endocrinology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00710.x","article-title":"Role of vitamin D in the pathogenesis of type 2 diabetes mellitus","volume":"10","author":"Palomer","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/BF00422375","article-title":"Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians","volume":"38","author":"Boucher","year":"1995","journal-title":"Diabetologia"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/79.5.820","article-title":"Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction","volume":"79","author":"Boucher","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e3573","DOI":"10.1002\/dmrr.3573","article-title":"Melatonin receptor gene polymorphisms as a risk factor in patients with diabetic peripheral neuropathy","volume":"38","author":"Ocak","year":"2022","journal-title":"Diabetes\/metabol Res Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S482824","article-title":"Diabetic peripheral neuropathy and glycemia risk index in type 2 diabetes: A cross-sectional study","volume":"17","author":"Tang","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12944-023-01865-5","article-title":"The mediating role of HbA1c in the association between elevated low-density lipoprotein cholesterol levels and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus","volume":"22","author":"Zhang","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1758-5996-6-139","article-title":"The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c","volume":"6","author":"Xu","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0212574","DOI":"10.1371\/journal.pone.0212574","article-title":"The risk factors for diabetic peripheral neuropathy: a meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4137\/bmi.s38440","article-title":"Significance of HbA1c test in diagnosis and prognosis of diabetic patients","volume":"11","author":"Sherwani","year":"2016","journal-title":"biomark Insights"},{"key":"B37","doi-asserted-by":"publisher","first-page":"107971","DOI":"10.1016\/j.jdiacomp.2021.107971","article-title":"Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes\u2014A prospective cohort study","volume":"35","author":"Dai","year":"2021","journal-title":"J Diabetes Its Complicat"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.6b00753","article-title":"Comparison of the predictive performance and interpretability of random forest and linear models on benchmark data sets","volume":"57","author":"Robinson","year":"2017","journal-title":"J Chem Inf Model"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1740545\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:52:08Z","timestamp":1767768728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1740545\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":38,"alternative-id":["10.3389\/fendo.2025.1740545"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1740545","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1740545"}}